Zanubrutinib: A novel BTK inhibitor in chronic lymphocytic leukemia and non-hodgkin lymphoma

Research output: Contribution to journal › Comment / Debate › Other › peer-review

Original language	English
Pages (from-to)	32-34
Number of pages	3
Journal	Clinical Advances in Hematology & Oncology
Volume	17
Issue number	1
Publication status	Published - Jan 2019
Externally published	Yes

Access to Document

@article{2a94d960dafb4ad98689503e43b571d5,

title = "Zanubrutinib: A novel BTK inhibitor in chronic lymphocytic leukemia and non-hodgkin lymphoma",

author = "Tam, {Constantine S.}",

year = "2019",

month = jan,

language = "English",

volume = "17",

pages = "32--34",

journal = "Clinical Advances in Hematology & Oncology",

issn = "1543-0790",

publisher = "Millennium Medical Publishing, Inc.",

number = "1",

}

TY - JOUR

T1 - Zanubrutinib

T2 - A novel BTK inhibitor in chronic lymphocytic leukemia and non-hodgkin lymphoma

AU - Tam, Constantine S.

PY - 2019/1

Y1 - 2019/1

UR - http://www.scopus.com/inward/record.url?scp=85061802158&partnerID=8YFLogxK

M3 - Comment / Debate

C2 - 30843894

AN - SCOPUS:85061802158

SN - 1543-0790

VL - 17

SP - 32

EP - 34

JO - Clinical Advances in Hematology & Oncology

JF - Clinical Advances in Hematology & Oncology

IS - 1

ER -